Previous 10 | Next 10 |
home / stock / bvnkf / bvnkf news
Bavarian Nordic ( OTCPK:BVNKF ) ( OTCPK:BVNRY ) ( BAVN ) said the EU has ordered an additional 170K doses of the company's monkeypox vaccine Imvanex which will be made available to EU Member States, Norway and Iceland. The Denmark-based company noted that the ...
A new study has raised questions over the protection generated by the monkeypox vaccine developed by Danish biotech Bavarian Nordic A/S ( OTCPK:BVNKF ) ( OTCPK:BVNRY ) and a recently-adopted strategy in the U.S. and Europe to increase its supplies. The study conducted by res...
The U.S. Department of Health and Human Services (HHS) on Monday said it would provide about $11M to fund and support the fill and finish of Bavarian Nordic's ( OTCPK:BVNRY ) ( OTCPK:BVNKF ) Jynneos monkeypox vaccine at the company's U.S. contract manufacturer. The Danish ...
Biden administration health officials will testify before the Senate Health, Education, Labor and Pensions Committee at a hearing in mid-September, Bloomberg reported. On August 23, Sen. Patty Murray (D-Wash.), chairwoman of the committee, sent a letter to Dawn O'Conne...
Bavarian Nordic A/S (BVNKF) Q2 2022 Earnings Conference Call August 24, 2022 8:00 AM ET Company Participants Rolf Sass – Investor Relations Paul Chaplin – President and Chief Executive Officer Henrik Juuel – Executive Vice President Con...
The following slide deck was published by Bavarian Nordic A/S in conjunction with their 2022 Q2 earnings call. For further details see: Bavarian Nordic A/S 2022 Q2 - Results - Earnings Call Presentation
The Biden administration Thursday said it will allow states on August 22 to begin placeing orders for 1.8M additional doses of Bavarian Nordic's ( OTCPK:BVNKF ) Jynneos monkeypox vaccine. The White House noted that jurisdictions that are administering the shot intradermall...
Bavarian Nordic ( OTCPK:BVNRY ) ( OTCPK:BVNKF ) on Thursday said it had entered into a deal with U.S. contract manufacturer Grand River Aseptic Manufacturing for fill and finish of its Jynneos monkeypox vaccine. The Danish company's shot has been in high demand amidst ...
Bavarian Nordic ( OTCPK:BVNKF ) ( OTCPK:BVNRY ) is exploring the possibility of outsourcing some of the manufacturing, including technology transfer, of its monekypox vaccine to a contract manufacturer in the U.S. as demand surpasses the supply of the only approved vaccine ...
According to the latest data compiled by the Centers for Disease Control and Prevention (CDC), the recent monkeypox outbreak has led to 10,392 cases as of Wednesday. The country has added 900 cases on Wednesday alone per the Our World in Data project, a public online data hub base...
News, Short Squeeze, Breakout and More Instantly...
Bavarian Nordic R/I Ord Company Name:
BVNKF Stock Symbol:
OTCMKTS Market:
Regulatory review of the single-dose CHIKV VLP vaccine candidate for immunization to prevent disease caused by chikungunya virus infection in individuals 12 years of age and older is now underway in both the EU and in the U.S. COPENHAGEN, Denmark, June 26, 2024 – Bavarian Nordic ...
First regulatory submission completed for CHIKV VLP seeking approval of the vaccine candidate for immunization against chikungunya virus infection in individuals 12 years of age and older Represents first BLA for a chikungunya vaccine for adolescents COPENHAGEN, Denmark, June 17, 2024...
COPENHAGEN, Denmark, April 29, 2024 – Bavarian Nordic A/S (OMX: BAVA) today announced that it has initiated the rolling submission process with the U.S. Food and Drug Administration (FDA) for a Biologics License Application (BLA) for the licensure of its CHIKV VLP vaccine candidate for i...